Fulcrum Therapeutics to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call and Webcast on Tuesday, February 25, 2025, at 8:00 a.m. ET

Core Viewpoint - Fulcrum Therapeutics, Inc. is set to release its fourth quarter and full year 2024 financial results on February 25, 2025, and will host a conference call to discuss these results and recent corporate developments [1]. Group 1: Financial Results Announcement - The financial results will be released before the U.S. financial markets open on February 25, 2025 [1]. - A conference call and webcast will take place at 8:00 a.m. ET on the same day to discuss the results [1]. Group 2: Company Overview - Fulcrum Therapeutics is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases [3]. - The company's lead program is pociredir, aimed at increasing fetal hemoglobin expression for treating sickle cell disease [3]. - Fulcrum employs proprietary technology to identify drug targets that can modulate gene expression to address the root causes of gene mis-expression [3].